203 related articles for article (PubMed ID: 15742329)
1. Immunocytochemical evaluation of thyroid neoplasms on thin-layer smears from fine-needle aspiration biopsies.
Rossi ED; Raffaelli M; Minimo C; Mule A; Lombardi CP; Vecchio FM; Fadda G
Cancer; 2005 Apr; 105(2):87-95. PubMed ID: 15742329
[TBL] [Abstract][Full Text] [Related]
2. Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology.
Fadda G; Rossi ED; Raffaelli M; Pontecorvi A; Sioletic S; Morassi F; Lombardi CP; Zannoni GF; Rindi G
Eur J Endocrinol; 2011 Sep; 165(3):447-53. PubMed ID: 21724837
[TBL] [Abstract][Full Text] [Related]
3. The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience.
Rossi ED; Straccia P; Martini M; Revelli L; Lombardi CP; Pontecorvi A; Fadda G
Cancer Cytopathol; 2014 May; 122(5):359-67. PubMed ID: 24474727
[TBL] [Abstract][Full Text] [Related]
4. Relevance of immunocytochemistry on thin-layer cytology in thyroid lesions suspicious for medullary carcinoma: a case-control study.
Rossi ED; Raffaelli M; Mulè A; Zannoni GF; Pontecorvi A; Santeusanio G; Minimo C; Fadda G
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):548-53. PubMed ID: 18685492
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid.
Rossi ED; Raffaelli M; Mule' A; Miraglia A; Lombardi CP; Vecchio FM; Fadda G
Histopathology; 2006 Jun; 48(7):795-800. PubMed ID: 16722927
[TBL] [Abstract][Full Text] [Related]
6. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
[TBL] [Abstract][Full Text] [Related]
7. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
[TBL] [Abstract][Full Text] [Related]
9. [Fine-needle aspiration biopsy of the thyroid nodule: uses and limitations].
Hayashi N; Kitaoka M
Nihon Rinsho; 2007 Nov; 65(11):2003-7. PubMed ID: 18018562
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.
Zhu X; Sun T; Lu H; Zhou X; Lu Y; Cai X; Zhu X
J Clin Pathol; 2010 Sep; 63(9):786-9. PubMed ID: 20644217
[TBL] [Abstract][Full Text] [Related]
11. Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining.
Nasser SM; Pitman MB; Pilch BZ; Faquin WC
Cancer; 2000 Oct; 90(5):307-11. PubMed ID: 11038428
[TBL] [Abstract][Full Text] [Related]
12. Fine-needle aspiration of the macrofollicular and microfollicular subtypes of the follicular variant of papillary carcinoma of the thyroid.
Mesonero CE; Jugle JE; Wilbur DC; Nayar R
Cancer; 1998 Aug; 84(4):235-44. PubMed ID: 9723599
[TBL] [Abstract][Full Text] [Related]
13. Liquid-based cytology in fine-needle aspiration biopsies of the thyroid gland.
Fadda G; Rossi ED
Acta Cytol; 2011; 55(5):389-400. PubMed ID: 21986164
[TBL] [Abstract][Full Text] [Related]
14. Atypical thyroid nodules express both HBME-1 and Galectin-3, two phenotypic markers of papillary thyroid carcinoma.
Coli A; Bigotti G; Parente P; Federico F; Castri F; Massi G
J Exp Clin Cancer Res; 2007 Jun; 26(2):221-7. PubMed ID: 17725102
[TBL] [Abstract][Full Text] [Related]
15. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
16. Utility of fine-needle aspiration cytology and frozen-section examination in the operative management of thyroid nodules.
Davoudi MM; Yeh KA; Wei JP
Am Surg; 1997 Dec; 63(12):1084-9; discussion 1089-90. PubMed ID: 9393257
[TBL] [Abstract][Full Text] [Related]
17. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
Aron M; Kapila K; Verma K
Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
[TBL] [Abstract][Full Text] [Related]
18. [The value of fine-needle aspiration biopsy (FNAB) in the differential diagnosis of the "cold" thyroid nodule].
Passler C; Prager M; Scheuba C; Kaserer K; Flores JA; Vierhapper H; Niederle B
Wien Klin Wochenschr; 1999 Mar; 111(6):240-5. PubMed ID: 10234779
[TBL] [Abstract][Full Text] [Related]
19. The role of fine-needle aspiration performed with liquid-based cytology in the surgical management of thyroid lesions.
Ardito G; Rossi ED; Revelli L; Moschella F; Giustozzi E; Fadda G; Marzola MC; Rubello D
In Vivo; 2010; 24(3):333-7. PubMed ID: 20555009
[TBL] [Abstract][Full Text] [Related]
20. CD117: a novel ancillary marker for papillary thyroid carcinoma in fine-needle aspiration biopsies.
Pusztaszeri MP; Sadow PM; Faquin WC
Cancer Cytopathol; 2014 Aug; 122(8):596-603. PubMed ID: 24920192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
